WO2023139605 - LYSIN POLYPEPTIDES AND COMPOSITIONS THEREOF AGAINST URINARY TRACT INFECTION CAUSED BY DRUG-RESISTANT GRAM- NEGATIVE BACTERIA
National phase entry is expected:
Publication Number
WO/2023/139605
Publication Date
27.07.2023
International Application No.
PCT/IN2023/050059
International Filing Date
19.01.2023
Title **
[English]
LYSIN POLYPEPTIDES AND COMPOSITIONS THEREOF AGAINST URINARY TRACT INFECTION CAUSED BY DRUG-RESISTANT GRAM- NEGATIVE BACTERIA
[French]
POLYPEPTIDES DE LYSINE ET COMPOSITIONS DE CEUX-CI CONTRE UNE INFECTION DES VOIES URINAIRES PROVOQUÉE PAR DES BACTÉRIES À GRAM NÉGATIF RÉSISTANTES AUX MÉDICAMENTS
Applicants **
TECHINVENTION LIFECARE PVT. LTD.
BIOGRIT TECHNOLOGIES INC
Inventors
SYED, Ahmed S
SYED, Safia
HANIF, Sarmad
BAJPAI, Urmi
DAS, Ritam
CHAVAN, Bhakti
Priority Data
202221003315
20.01.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2042 | |
| EPO | Filing, Examination, Granting | 11781 | |
| Japan | Filing, Examination, Granting | 2133 | |
| South Korea | Filing, Examination, Granting | 1961 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
23,257
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention provides a lysin polypeptide comprising an amino acid sequence having at least 80% or at least 85% or at least 90% or at least 95% identity to a sequence selected from the group consisting of SEQ ID NO: 1-SEQ ID NO: 16, or a fragment thereof having lysin activity. The present invention also provides a composition for prophylaxis and/or treatment of infections caused by Gram Negative Bacteria, the composition of lysin polypeptide comprising an amino acid sequence having at least 80% or at least 85% or at least 90% or at least 95% identity to a sequence selected from the group consisting of SEQ ID NO: 1-SEQ ID NO: 16, or a fragment thereof having lysin activity.[French]
La présente invention concerne un polypeptide de lysine comprenant une séquence d'acides aminés ayant au moins 80 % ou au moins 85 % ou au moins 90 % ou au moins 95 % d'identité avec une séquence choisie dans le groupe constitué par SEQ ID NO:1-SEQ ID NO:16, ou un fragment de celle-ci ayant une activité de lysine. La présente invention concerne également une composition pour la prophylaxie et/ou le traitement d'infections provoquées par des bactéries à Gram Négatif, la composition de polypeptide de lysine comprenant une séquence d'acides aminés ayant au moins 80 % ou au moins 85 % ou au moins 90 % ou au moins 95 % d'identité avec une séquence choisie dans le groupe constitué par SEQ ID NO:1-SEQ ID NO:16, ou un fragment de celle-ci ayant une activité de lysine.